Objective: to analyze the short-term and long-term effects of panretinal photocoagulation in the treatment of proliferative diabetic retinopathy, and to explore the effect of this treatment method on the choroidal thi...Objective: to analyze the short-term and long-term effects of panretinal photocoagulation in the treatment of proliferative diabetic retinopathy, and to explore the effect of this treatment method on the choroidal thickness and the safety of the treatment. Methods: 80 patients with proliferative diabetic retinopathy who were treated in our hospital were sampled by cluster sampling, and the inclusion period ranged from March 2019 to March 2021. According to different treatment methods, the patients were divided into two groups for controlled study, namely the reference group (40 cases, drug treatment) and the observation group (40 cases, drug + panretinal photocoagulation). The following indexes were used to evaluate the clinical effect of the operation method in the observation group: before and after treatment, the two groups of short-term efficacy indexes (IOP, visual acuity) were compared and analyzed;before and after treatment, the choroidal thickness (ICT, SCT, NCT) of the two groups was compared and analyzed , TCT, SFCT);after treatment, the two groups of treatment safety (complications) were compared and analyzed, followed up for 12 months, and the long-term efficacy (disease progression, vision correction) of the two groups was compared and analyzed. Results: compared with the reference group, the visual acuity score of the observation group after treatment was more superior (P<0.05), and there was no significant difference in the intraocular pressure level between the two groups (P>0.05). Compared with the reference group, the thickness measurement results of ICT, SCT, NCT, TCT and SFCT in the observation group were significantly lower (P<0.05). There was no significant difference (P>0.05);from the perspective of long-term efficacy: compared with the reference group, the observation group had better control of disease progression and vision correction within 12 months (P<0.05). Conclusion: the short-term and long-term effects of panretinal photocoagulation in the treatment of proliferative diabetic retinopathy are ideal. This operation can effectively reduce the choroidal thickness, and has high safety. It is recommended for clinical use.展开更多
文摘Objective: to analyze the short-term and long-term effects of panretinal photocoagulation in the treatment of proliferative diabetic retinopathy, and to explore the effect of this treatment method on the choroidal thickness and the safety of the treatment. Methods: 80 patients with proliferative diabetic retinopathy who were treated in our hospital were sampled by cluster sampling, and the inclusion period ranged from March 2019 to March 2021. According to different treatment methods, the patients were divided into two groups for controlled study, namely the reference group (40 cases, drug treatment) and the observation group (40 cases, drug + panretinal photocoagulation). The following indexes were used to evaluate the clinical effect of the operation method in the observation group: before and after treatment, the two groups of short-term efficacy indexes (IOP, visual acuity) were compared and analyzed;before and after treatment, the choroidal thickness (ICT, SCT, NCT) of the two groups was compared and analyzed , TCT, SFCT);after treatment, the two groups of treatment safety (complications) were compared and analyzed, followed up for 12 months, and the long-term efficacy (disease progression, vision correction) of the two groups was compared and analyzed. Results: compared with the reference group, the visual acuity score of the observation group after treatment was more superior (P<0.05), and there was no significant difference in the intraocular pressure level between the two groups (P>0.05). Compared with the reference group, the thickness measurement results of ICT, SCT, NCT, TCT and SFCT in the observation group were significantly lower (P<0.05). There was no significant difference (P>0.05);from the perspective of long-term efficacy: compared with the reference group, the observation group had better control of disease progression and vision correction within 12 months (P<0.05). Conclusion: the short-term and long-term effects of panretinal photocoagulation in the treatment of proliferative diabetic retinopathy are ideal. This operation can effectively reduce the choroidal thickness, and has high safety. It is recommended for clinical use.
